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gene which caused amino acid to change from Thr to Met at
position aa118 and researched the effects of this mutation on
blood HBsAg screening test.
Methods: HBsAg Gene, which was ampliﬁed by PCR, was cloned
and sequenced, then mutational amino acids were recovered
the wild type at aa117 or/and aa118 position. By insertion of
HBsAg Genes, expressing vectors were constructed and transient
expressions were committed in 293T cells. Suspensions of cell
culture were collected and tested by the panel which contained
ten kinds of HBsAg testing kits provided by companies.
Result: The proﬁle of results tested by Panel were similar be-
tween express suspension of mutation HBsAg gene and donation
serum and most of kits but two failed. But the proﬁle was sig-
niﬁcant difference compared with normal quality control serum.
When mutation was recovered at 117 position, the proﬁle of re-
sults did not change. But mutation was recovered at 118 position,
the proﬁle of results changed, and all kits can effetely test this
HBsAg.
Conclusion:Mutation of HBsAg at 118 position which was changed
from T to M leaded to failure tests by most of kits.
PP-100 Induction of effective anti-HBV speciﬁc T cellular
responses with dendritic cells that modiﬁed by a
recombinant adenovirus vector expressing HBsAg
and CTLA-4 ScFv
Guoping Peng*,1, Cheng Zhou1, Wei Wu1, Hangping Yao1,
Jianming Qiu2, Feng Chen1, Haihong Zhu1, Zhi Chen1. 1National
Key Laboratory of Infectious Diseases, Institute of Infectious
Diseases, First Afﬁliated Hospital, Medical college, Zhejiang
University; 2Institute of Immunology, Zhejiang University
Objectives: To investigate the mechanism and evaluate the ther-
apeutic potential of Ad-S-ScFv transduced DCs in HBV transgenic
mice.
Methods: The ScFv of CTLA-4 was ligated and the recombinant
Ad-S and Ad-S-ScFv were constructed. DCs were transfected with
rAd (Ad-S-ScFv, Ad-S, etc), and HBV-Tg mice were randomly as-
signed to receive different rAd-transduced DCs twice at 3-week
intervals. The HBV speciﬁc IFN-γ+ CD8+ T cells proportion, the
HBsAg-speciﬁc T cellular proliferation and cytotoxic activity of
splenocytes were measured. The serum HBV markers and ALT
levels, the histology and the expression of HBcAg, HBsAg in
tissue samples of liver were also assessed. The expression and
phosphorlation level for the key components of the intracellular
signal pathway of MAPK and PI3K/Akt were detected.
Results: Compared with either DC/Ad-S or DNA immunization,
DC/Ad-S-ScFv can induce much stronger type I immune responses
and HBV-speciﬁc CTLs, and more signiﬁcantly reduce the titer
of serum HBsAg and HBV DNA, and also reduced the expression
of HBcAg and HBsAg in the liver of HBV-Tg mice. The phospho-
rlation expression of Erk1,2 in the liver tissue of DC/Ad-S-ScFv
immunized mice were signiﬁcant increased, but not for the the
PI3K/Akt signal protein.
Conclusion: Ad-S-ScFv transduced DCs may be a promising candi-
date for a CTL-based vaccine for chronic HBV infection, and the
combination with other antiviral strategy could probably acquire
the complete clearance of HBV DNA.
PP-101 Pattern of hepatitis B ‘e’ antigen (HBeAg) in
hepatitis B surface antigen (HBsAg) conﬁrmed
positive cases
Rabindra Nepal*,1, Dhundi Raj Sharma2. 1National Reference
Laboratory; 2Yeti Health Science Academy
Objective: The aim of this study was to explore the pattern
of HBeAg status in HBsAg true positive cases attending National
Reference Laboratory of Nepal.
Materials and Methods: Secondary data were collected by record
review. Serum specimens conﬁrmed for HBsAg positive cases
(n=512), by neutralization method using bioKit, Spain, were sub-
jected to semi-automatic enzyme immunoassay (EIA) GB, Taiwan
for the detection of HBeAg during the period of November 2006
to February 2009. Qualitative results were calculated by cut-off
formula provided in the kit insert and the produced data were
analyzed.
Results: Of the true HBsAg positive (n=512) cases, 76.17% (n=390)
were males and 23.83% (n=122) were females. Data showed that
29.49% (n=151) cases were found to be positive for HBeAg,
among which 31.28% (n=122) were males and 23.77% (n=29) were
females. Age wise distribution of HBeAg seropositivity showed
71.52% (n=108) cases were in the age group 21–50 years, the
most active and productive age group in Nepal.
Conclusion: Such higher prevalence of hepatitis B virus infection
in its actively multiplying phase poses a problem of greater
transmission rate in the communities. As males are more mobile
than females in Nepal our communities are exposed to more risk
of getting hepatitis B virus infection.
Similarly, HBeAg positive mothers may give birth to babies with
HBsAg positive status who ultimately become chronic carrier of
hepatitis B virus.
PP-102 The study of the CD4+CD25+treg induced by
human plasmacytoid dendritic cells from chronic
hepatitis B in vitro
Jun Hong*. Renmin Hospital of Wuhan University
Background: This study was undertaken to investigate whether
PDCs are involved in the generation of a higher proportion of
CD4+CD25+ Treg cells in chronic HBV infection compared with
healthy people.
Methods: The amount, phenotype, and function of Treg in CD4+
T cells primed by PDC from 46 chronic HBV patients, 25 healthy
controls, and 10 individuals with a resolved HBV infection were
studied by the ways of ﬂow cytometry, RT-PCR, ELISA and prolif-
eration assay.
Results: CD4+T cells primed by PDC from chronic HBV patient
were more effective than CD4+ T cells primed by PDC from
healthy controls and resolved HBV patients in suppressing the
HBcAg-speciﬁc proliferation and the interferon production. The
IL-10 and TGF-β1 could be also detectable in the supernatants
of PDC-primed CD4+ T cells. A higher percentage of Treg, de-
ﬁned as CD4, CD25, CD45RO, and CTLA-4-positive cells, was
detected within the population of CD4+ T cells primed by PDC
from chronic HBV patients compared with healthy controls and
individuals with a resolved HBV infection. Accordingly, CD25+Treg
from PDC-primed CD4+ T cells displayed a high Fox P3 messenger
RNA level. Depleting CD4+CD25+ Treg from CD4+ T cells primed by
PDC from chronic HBV patients, healthy volunteers and resolved
HBV patients made PDC-primed CD4+ T to lose the capability in
suppressing HBV-speciﬁc T-cell.
Conclusion: PDCs from the patients with chronic HBV infection
induce the generation of a higher proportion of CD4+CD25+ Treg
compared with the healthy peoples.
PP-103 Abnormal expression of TGF-β1 and IGF-II
associated with HBV replication in human
hepatoma tissues
Dengfu Yao*, Jing Qian, Shanshan Li, Yinzhu Bian. Research
Center of Clinical Medicine, Afﬁliated Hospital of Nantong
University, Nantong, China
Background: The abnormality of many growth factor expressions
involved in the formation and development of HCC, and asscosi-
ated with the alteration of gene methylation status. However,
their molecular mechanism and expression rule remains not too
clear. In the present study, we investigated the relationship
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between HBV replication and the expressions of transforming
growth factor (TGF)-β1 and insulin-like growth factor-II (IGF-II)
in tissues of hepatocellular carcinoma (HCC).
Methods: Liver HBV-DNA was detected by in situ molecular hy-
bridization technique, and the expressions of TGF-β1 and IGF-II
were detected by the immunohistochemistry, and TGF-β1 mRNA
and IGF-II mRNA were ampliﬁed by nested-PCR assay in HCCs
and their self-control non- cancerous tissues. The relationship
was investigated between TGF-β1 or IGF-II expression and HBV
replication or their clinical pathological characteristics.
Results: The stronger expressions (83.3%) of TGF-β1 and IGF-II
were found, and the incidences of TGF-β1 mRNA and IGF-II mRNA
were 100% in HCC tissues. A signiﬁcant difference was presented
between in HCC tissue and in non-cancerous liver tissues
(P<0.01). The positive rate of TGF-β1 in HCC was correlated
to tumor differentiation, but neither to tumor size nor numbers
(P>0.05). The levels of TGF-β1 and IGF-II expression were
signiﬁcantly associated with HBV replication with higher HBV-
DNA-positive HCC (94.7%) than that in HBV-DNA-negative group.
Conclusion: TGF-β1 and IGF-II in HCC are overexpressed and as-
sociated withhepatic HBV replication and differentiation degree
of HCC.
PP-104 Chronic hepatitis B: molecular, epidemiological
and clinical features in northwest and central
Russia
Ekaterina Elpaeva, Elena Poretskova, Andrey Komissarov,
Maria Pisareva, Mikhail Grudinin, Elena Esaulenko*, Oleg Kiselov.
Research Institute of Inﬂuenza RAMS
Objectives: To reveal the HBV genotype distribution and clinical
differences between different genotypes in patients with chronic
hepatitis in 2 regions of Russia, to determine the structure of
HBV DNA fragments responsible for resistance to treatment.
Methods: HBV genotyping was carried out by original PCR
method. Sequencing with original primers was performed. Real
time PCR was used to determine viral load in patients’ blood
and liver biopsies. Disease severity was evaluated by clinical-
laboratory markers and morphology study.
Results: 325 patients with chronic hepatitis B (Mean age - 34
years. Female to male ratio - 2:1) were observed. HBV genotype
was determined in 294 patients from Saint Petersburg region
and 31 patients from Central part of Russia (Perm city). HBV D
genotype was revealed in 96% of cases in North West and in 67% of
cases in Central Russia. In the rest of cases A genotype was deter-
mined. More severe disease with necro-inﬂammatory inﬁltration
and ﬁbrosis progression was diagnosed in patients with HBV A
genotype. Some patients from this group had hepatocirrhosis.
95% of patients with HBV D genotype were HBeAg-negative. HBV
polymerase gene fragment sequencing from 28 patients revealed
high variability of viral genome and YMDD-motif characteristic
for wild type (lamivudin susceptible).
Conclusion: HBV genotypes A and D are circulating in North West
and Central Russia. The percentage of prevalent D genotype is
much higher in the North West region. Prevalence of mutant
D genotype HBV enforces to include nucleoside analogues in
therapeutic course of HBV chronic patients.
PP-105 Development of an ELISA kit for detection of
HBsAg in human serum
Marjan Rahsaz*,1, Daryoush Tayyebi 2. 1Shiraz Transplantation
Research Center; 2Islamic Azad University, Kazeroun Branch
Background: Hepatitis B virus, the cause of serum hepatitis, is
classiﬁed as a hepadnavirus. HBV is responsible for acute and
chronic infections and may ultimately lead to cirrhosis or pri-
mary hepatocellular carcinoma. HBV have various antigens, the
important of which is surface antigen or HBsAg.
The particles containing HBsAg are antigenically complex. In con-
trast to the other HBV antigens, HBsAg is an important diagnostic
marker of an active hepatitis B infection. Emphasis of this study
is to develop a direct sandwich ELISA method for detection of
HBsAg in the human serum.
Methods: In summary, the surface of well of microplate was
coated by mouse monoclonal anti-HBs with the concentration of
1 J.1g1mTl.he serum or plasma sample added to the wells of
microplate after they had been saturated by BSA. Then, diluted
anti-HBs-HRP (1/8000) was added to each well which was able
to connect to the trapped HBsAg. The ﬁnal colorometric detec-
tion of HBsAg is performed by adding a solution of substrate of
peroxidase enzyme to each well. The color intensity is directly
proportional to the concentration of HBsAg in serum.
Results: The sensitivity and speciﬁcity of the developed method
was studied on 1350 serum samples. The results indicated a 96%
sensitivity and 98.8% speciﬁcity. The precision of this method
was determined by the %CV for inter-assay and intra-assay.
Conclusions:We can develop a direct sandwich ELISA method for
detection of HBsAg in the human serum with 96% sensitivity and
98.8% speciﬁcity.
PP-106 Analysis of lymphocyte subsets of peripheral
blood in patients with acute self-limited
hepatitis B
Bo Liu, Yanping Han, Yuan Liu, Yang Cao, Lianhua Kong, Jun Li *.
The First Afﬁliated Hospital with Nanjing Medical University
Objectives: To investigate changes and signiﬁcance of lympho-
cyte subsets (T lymphocytes, B lymphocytes, NK cells and T cell
subsets) of peripheral blood in patients with acute self-limited
hepatitis B (AHB) with changes.
Methods: By ﬂow cytometry (FCM), immune cells of peripheral
blood were comparied among 23 cases of self-limited acute hep-
atitis B patients, 36 patients with chronic hepatitis B (CHB) and
32 healthy controls; CD4+/CD8+ and ALT were monitored dynam-
iclly, meanwile the relation between T lymphocyte subsets and
ALT were explored.
Results: The level of CD3+ T cells (75.02±8.71%), CD3+CD4+T
cells (43.32±6.73%) and the ratio of CD4+/CD8+ (2.35±0.51%)
of AHB have signiﬁcantly increased compared to CHB group
(62.48±11.33%, 33.07±9.67%, 1.14±0.31% respectively) and
healthy group (64.00±11.54%, 34.41±7.53%, 1.41±0.61% respec-
tively); Dynamic monitoring of CD4+/CD8+, ALT, CD4+/CD8+ had
an increased trend, accompanied by lower ALT. And CD4+/CD8+
had no signiﬁcant relation to HBV-DNA for HBV-DNA positive AHB.
Conclusion: Immune status of AHB, compared to CHB and healthy
controls, were signiﬁcantly different and changes of T lympho-
cyte subsets were related to progress of disease.
PP-107 Up-regulation of expression of B7-H1 and its
receptor PD-1 on PBMC by HBeAg
Jun Li *, Yaping Han, Bo Liu, Jie Cai, Yuan Liu, Lianhua Kong,
Zuhu Huang. The First Afﬁliated Hospital with Nanjing Medical
University
Objectives: To study HBeAg does impact on molecule expression
of B7-H1 and PD-1 as well as TLR2 on PBMC.
Methods: PBMC from different infectious status of CHB patients
were stimulated by recombinant HBeAg, and expression of B7-
H1, PD-1 and TLR2 on PBMC before and after stimulation as well
as changes in lymphocyte subsets were quantitativly analysized
on FACS, changes in expression of PBMC surface receptor above
were further observed by using blocked method of HBeAb, in or-
der to conﬁrm HBeAg-speciﬁc function, while analysizing growth
and decline of cytokines in culture supernatant before and after
stimulation.
Results: When PBMC from HBeAg-negative CHB patients and
